Literature DB >> 8212541

The extracellular matrix in sarcomatoid carcinomas of the breast.

M Guarino1, D Reale, G Micoli.   

Abstract

The distribution of the main extracellular matrix components has been investigated immunohistochemically in four cases of breast sarcomatoid carcinomas. The histogenesis of these tumours is still unclear, but most evidence suggests that the sarcomatous component originates from mesenchymal conversion of carcinomatous cells. We found that carcinomatous portions of the tumours were associated with linear basement membrane-like deposition of laminin, type IV collagen and heparan sulphate proteoglycan that partially circumscribed the epithelial nests. The sarcomatous components produced an extracellular matrix immunoreactive to fibronectin, type I, III and VI collagens and tenascin. However, in two cases, in some sarcomatous areas, focal pericellular staining for antibodies to laminin and type IV collagen was seen. These results indicate that modifications observed in the double tissue component of these tumours involve not only the cell shape and the cytoskeleton, but also the components of the extracellular matrix. The significance of these findings and their relevance in the understanding of the phenotypic pattern changes of these biphasic tumours are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8212541     DOI: 10.1007/bf01606587

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  26 in total

Review 1.  Matrix regulation of cell shape and gene expression.

Authors:  J A McDonald
Journal:  Curr Opin Cell Biol       Date:  1989-10       Impact factor: 8.382

2.  Generation of fibroblast-like cells from cloned epithelial mammary cells in vitro: a possible new cell type.

Authors:  R Dulbecco; M Henahan; M Bowman; S Okada; H Battifora; M Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

3.  Preparation and use in immunohistology of antibodies specific for type I and type III collagen and procollagen.

Authors:  H Nowack; S Gay; G Wick; U Becker; R Timpl
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

Review 4.  Formation of cytoskeletal elements during mouse embryogenesis. III. Primary mesenchymal cells and the first appearance of vimentin filaments.

Authors:  W W Franke; C Grund; C Kuhn; B W Jackson; K Illmensee
Journal:  Differentiation       Date:  1982       Impact factor: 3.880

5.  Sarcomatoid carcinoma of the breast: an immunohistochemical study of six cases.

Authors:  J M Meis; N G Ordóñez; H S Gallager
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

6.  Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line.

Authors:  B Boyer; G C Tucker; A M Vallés; J Gavrilovic; J P Thiery
Journal:  Int J Cancer Suppl       Date:  1989

Review 7.  What distinguishes tenascin from fibronectin?

Authors:  R Chiquet-Ehrismann
Journal:  FASEB J       Date:  1990-06       Impact factor: 5.191

8.  Spindle cell carcinoma: ultrastructural evidence of squamous origin and collagen production by the tumor cells.

Authors:  H Battifora
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

9.  Immunocytochemical investigation of intermediate filament proteins and epithelial membrane antigen in spindle cell tumours of the breast.

Authors:  I O Ellis; J Bell; J E Ronan; C W Elston; R W Blamey
Journal:  J Pathol       Date:  1988-02       Impact factor: 7.996

10.  Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells.

Authors:  G Greenburg; E D Hay
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

View more
  2 in total

Review 1.  A tense situation: forcing tumour progression.

Authors:  Darci T Butcher; Tamara Alliston; Valerie M Weaver
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

2.  Actin-towards a deeper understanding of the relationship between tissue context, cellular function and tumorigenesis.

Authors:  Virginia A Spencer
Journal:  Cancers (Basel)       Date:  2011-12-14       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.